Device Trial Radar · NCT05485922
Performance of a Single-use Intermittent Micro-hole Zone Catheter
Last checked: Nov 20, 2026Latest source record: Mar 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
Sep 23, 2022
Primary completion
Nov 4, 2022
Study completion Nov 4, 2022
Sponsor
- Lead sponsor
- Coloplast A/SNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 3, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this randomized, controlled crossover study was to assess the performance of a new micro-hole zone catheter compared to a conventional 2-eyelet catheter in 42 male intermittent catheter users. The main objective of this study was to demonstrate superiority of the micro-hole zone catheter in terms of number of flow-stop episodes and residual volume at first flow-stop, with the catheterization performed by a health care professional in a hospital setting compared to a conventional two-eyelet catheter.
Conditions
- Urinary Incontinence
- Retention, Urinary
Interventions
Investigational device - intermittent catheter with a micro-hole zoneDevice
The investigational device was a urinary catheter for bladder drainage through the urethra. The product is for intermittent use.
Comparator device -VaPro intermittent catheterDevice
The comparator device is a urinary catheter for bladder drainage through the urethra. The product is for intermittent use.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Flow-stop EpisodesTime frame: Immediately after the procedure/catheterization
- Residual Urine at 1st Flow-stopTime frame: When the first flow-stop appeared, the amount of voided urine was measured.
- Number of Flow-stop EpisodesTime frame: Immediately after catheterisation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sanos Clinic
Gandrup, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.